| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.092 | 0.1 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.1 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.1 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.078 | 0.1 |